Nuvation Bio Inc. Class A Common Stock vs PACCAR Inc. Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $5 (market cap $1.74B), while PACCAR Inc. Common Stock trades at $108.04 (market cap $57.72B). The key difference: PACCAR Inc. Common Stock is far larger — about 33.2× Nuvation Bio Inc. Class A Common Stock's market cap, and PACCAR Inc. Common Stock pays a 1.28% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 1 Days and PACCAR Inc. Common Stock for 1 Days on average.
| NUVB | PCAR | |
|---|---|---|
Market Cap | $1.74B | $57.72B |
Volume | 9,289,619 | 3,769,505 |
Sector | Health | Industrials |
52-Week High | $9.54 | $138.21 |
52-Week Low | $3.41 | $93.00 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $1.33B | $63.58B |
Dividend Yield | — | 1.28% |
Trailing returns across standard periods
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →PACCAR designs and manufactures heavy-duty trucks under brands including Peterbilt, Kenworth, and DAF. It also provides parts, financial services, and technology for commercial vehicles.
Read more on PCAR →